UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000015582 |
|---|---|
| Receipt number | R000018107 |
| Scientific Title | Phase I trial of Afatinib intercalated with Carboplatin/Pemetrexed Chemotherapy in advanced non-squamous non-small-cell lung cancer harboring EGFR mutations. |
| Date of disclosure of the study information | 2014/11/01 |
| Last modified on | 2018/11/05 10:43:43 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2014/11/01 16:42:12 | ||
| 2 | Update | 2015/03/16 22:04:50 | Recruitment status |
|
| 3 | Update | 2016/05/02 14:52:37 | Name of primary person or sponsor Organization |
|
| 4 | Update | 2016/11/02 18:47:24 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete |
|
| 5 | Update | 2017/05/06 12:32:02 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
| 6 | Update | 2017/11/03 19:00:39 | Results Results Other related information Other related information |
|
| 7 | Update | 2018/11/05 10:43:44 | Recruitment status Publication of results Other related information Other related information |
